LEAP-BIO, a COSME project, is opening a call for Expression of Interest concerning development of IP licensing intermediary services for early-stage assets in pharma and biotech. If your organisation has relevant assets within this industry, keep reading to know more and apply.
The LEAP-BIO project aims to address a lack of intermediary services towards IP licensing and exploitation of early-stage assets in key-target European regions/countries, such as Portugal, Spain, France, Italy and Belgium (Wallonia region). The goal of the LEAP-BIO project is to leverage the extensive expertise and networks of the consortium to develop an early-stage focused IP licensing intermediary service for biopharma institutes, SMEs and start-ups in the target regions.
Under their call for Expression of Interest, the LEAP-BIO project is currently seeking applicants from key target regions , who own early-stage assets at the discovery or preclinical stage that match the licensing interests of big pharma and well-funded biotech companies. More information on the big pharma & biotech interests can be found in the “Interests from big pharma & biotech” document (download here).
What’s in it for you?
Applicants will gain access to a specialised free-of-charge IP licensing intermediary service, designed to facilitate the complex process of licensing assets within the biopharma industry. By applying to this call, applicants will increase their chances of securing a successful licensing deal, as their assets will be showcased to companies with matching interests. Successful applicants will also have the opportunity to receive support from LEAP-BIO during negotiations, including assistance with negotiating term-sheets.
Who can apply?
The assets submitted must meet the following criteria:
- Early-stage assets (discovery and preclinical stages)
- Ready for out-license
- Aligned with the topics of interest listed in the pdf document “Interests from big pharma & biotech”
- Country / Regions: Portugal, Spain, France, Italy and Belgium (Wallonia region)
How to apply?
Companies interested in submitting early-stage assets should complete the Asset forms (download here) only with non-confidential information, and send it to imm-techtransfer@medicina.ulisboa.pt before the stage deadline.
Expressions of Interest (EoI) will be accepted in two independent stages.
1st stage: - CLOSED
- Open: 17th of May (Wednesday), 9AM CET time
- Closure: 4th of July (Tuesday), 6PM CET time
2nd stage: OPEN for applications
- Open: 5th of September (Tuesday), 9AM CET time
- Closure: 19th of October (Thursday), 6PM CET time
More information
For more details on the call for Expression of Interest, please check the “LEAP-BIO EoI” document (download here).
If you have any questions or doubts, please contact iMM’s Technology Transfer Office (imm-techtransfer@medicina.ulisboa.pt)
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.